CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.

AstraZeneca

Status: Completed

Conditions: Cardiovascular Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00713960

NIS-CDK-DUM-2008/1

Details and patient eligibility

About

Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice

Enrollment: 2,193 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients in secondary prevention of cardiopathy (ischaemic heart disease, claudication intermittence, thrombotic apoplexy cerebri, diabetes) who are not followed in an outpatient department.

Exclusion criteria

• Patients who suffer from diabetic nephropathy will be excluded
• According to the general practitioners appraisal, patients who suffer from severe co morbidity can be excluded as well.

Trial design

2,193 participants in 1 patient group

1

Description:

Patients in secondary prevention of cardiovascular disease in primary care